Bone composition: relationship to bone fragility and antiosteoporotic drug effects
about
Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspectsIn Vitro Bone Cell Models: Impact of Fluid Shear Stress on Bone FormationVibrational spectroscopic imaging for the evaluation of matrix and mineral chemistryCisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort StudyMultiscale Predictors of Femoral Neck In Situ Strength in Aging Women: Contributions of BMD, Cortical Porosity, Reference Point Indentation, and Nonenzymatic Glycation.Extracellular calcium promotes bone formation from bone marrow mesenchymal stem cells by amplifying the effects of BMP-2 on SMAD signallingExamining the Relationships Between Bone Tissue Composition, Compositional Heterogeneity, and Fragility Fracture: A Matched Case-Controlled FTIRI Study.Matricellular proteins as regulators of cancer metastasis to bone.Novel assessment tools for osteoporosis diagnosis and treatment.A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture.Non-destructive NIR spectral imaging assessment of bone water: Comparison to MRI measurements.Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative.The Formation of Calcified Nanospherites during Micropetrosis Represents a Unique Mineralization Mechanism in Aged Human Bone.Tissue-Level Mechanical Properties of Bone Contributing to Fracture Risk.Biomimetics of Bone Implants: The Regenerative Road.Vibrational spectroscopic techniques to assess bone quality.Synthesis and characterization of CaO-loaded electrospun matrices for bone tissue engineering.Mechanical basis of bone strength: influence of bone material, bone structure and muscle actionBone quality assessment techniques: geometric, compositional, and mechanical characterization from macroscale to nanoscaleStrategies Developed to Induce, Direct, and Potentiate Bone Healing.Effects of strength training and raloxifene on femoral neck metabolism and microarchitecture of aging female Wistar rats.Preventing Obstructions of Nanosized Drug Delivery Systems by the Extracellular Matrix.Exercise and bone health across the lifespan.Model of hindlimb unloading in adult female rats: Characterizing bone physicochemical, microstructural, and biomechanical properties.Different compact hybrid Langmuir-Blodgett-film coatings modify biomineralization and the ability of osteoblasts to grow.Examining tissue composition, whole-bone morphology and mechanical behavior of GorabPrx1 mice tibiae: A mouse model of premature aging.Elevated solute transport at sites of diffuse matrix damage in cortical bone: Implications on bone repair.Enzyme replacement therapy prevents loss of bone and fat mass in murine homocystinuria.The Content of Structural and Trace Elements in the Knee Joint Tissues.Decellularized Bone Matrix Scaffold for Bone Regeneration.Altered Bone Mechanics, Architecture and Composition in the Skeleton of TIMP-3-Deficient Mice.Nano-confinement-driven enhanced magnetic relaxivity of SPIONs for targeted tumor bioimaging.The Potential of Probiotics as a Therapy for Osteoporosis.Immunoporosis: Immunology of Osteoporosis-Role of T Cells.Osteogenesis imperfecta and therapeutics.Label-free Raman spectroscopy provides early determination and precise localization of breast cancer-colonized bone alterations.3D bioactive composite scaffolds for bone tissue engineering.Nanoprobes for Multimodal Visualization of Bone Mineral Phase in Magnetic Resonance and Near-Infrared Optical Imaging.An In Vitro Model for the Development of Mature Bone Containing an Osteocyte NetworkBiomimetic matrices for rapidly forming mineralized bone tissue based on stem cell-mediated osteogenesis
P2860
Q27025945-B4BBDFD3-445A-4DB2-B9D7-464F44F83E63Q28069176-98EFADAF-7996-40B9-843F-6D7C46E45E98Q28393488-574FDBE4-5D19-4691-9468-AFEBD0C2FA4CQ36153146-0962B165-01D9-4FA7-8F93-1CE8574EBE62Q36355576-B5595A44-C2BC-4BE0-9758-94F21D6DB9D3Q36380663-47E79A7E-C954-4B88-9A5C-D0F3055BD9C0Q36889362-AB8D875A-4159-48D3-8F35-06AC59BB30FCQ36923653-E41348CE-EEA5-468D-9F2A-9D42F58ABABAQ38216229-B82874D8-9152-400D-A960-5813D408043BQ38585164-5B9E8D1A-93CC-43C4-8B7F-3A07DA18F3D3Q38699372-0D74F08D-810D-42D4-9952-C9469132D8CFQ38757607-1320627B-D691-49F9-B1AC-8944AECFEAB5Q38770855-0BD4A144-E5C9-401C-A57C-B0652312F100Q38855221-15F2D52C-15F9-4ED1-A125-A745D7BDBD16Q39121240-A5D51B5D-63C9-4115-8EFE-B3701C71A790Q39220959-F9FC7B6E-0C27-41B0-9D57-38C66AA01E6DQ40269118-2B195266-E9CD-449A-A190-15BC4B809E25Q41707116-0BC9D858-681A-466C-BC89-5F220629EBF2Q41720120-047DF6CC-20F4-4DD1-B05D-EE97963A11F1Q46141908-FCD8756C-0403-4A68-BD9F-70974186A7A6Q46213087-B44E3D19-166D-4A55-8854-F11DB082A435Q46264786-C87CEB71-806E-43CC-A7A8-407FD6725621Q47100094-FD4326BA-FBC9-4385-BE40-18D52425510BQ47131183-C4E5A368-DE9E-4F52-BC11-AB68A3C64F9CQ47191019-621B9223-C3FE-41E9-829D-0BEFE76B225EQ47376202-A810AF9D-E96A-4C91-9763-FE6E0D9B0E2FQ47664047-430A51F7-9224-4F80-8A49-4988E2733852Q47769278-52606E45-B3CB-40F7-B23D-51854F1C73E7Q47784339-FD182A81-96E6-4FE7-A8B7-36E50741BD27Q47850726-73814424-8A9E-476F-81EE-C2B89971C458Q48195251-7070249E-6724-4744-BDEC-43C27D4DF537Q50053775-DE91BBFD-543C-40E1-BC9C-82FE5E754986Q51800938-363D644F-3550-4EE4-B01B-EE6520C2DD48Q52576095-D7741F7A-36A1-4178-A436-3864C8E0BD3DQ52655586-7584E0D0-B0C8-48A9-90FB-E070FB1F2BC6Q52720773-34E62062-3B16-481C-B23D-FB14997B1A8DQ54966347-C6BBC770-74BE-481A-A297-4BC978EA75BAQ55664595-3210B91A-C3B3-4750-A0E7-BD0A50AB188BQ57838607-3C8D995F-AD7A-40BF-91F8-BDA485C13C7EQ58695615-CFB75CAE-58D3-4ABE-A08B-090F474EF124
P2860
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@ast
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@en
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@nl
type
label
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@ast
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@en
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@nl
prefLabel
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@ast
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@en
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@nl
P2860
P3181
P356
P1433
P1476
Bone composition: relationship to bone fragility and antiosteoporotic drug effects
@en
P2093
Adele L Boskey
P2860
P2888
P3181
P356
10.1038/BONEKEY.2013.181
P407
P577
2013-01-01T00:00:00Z
P6179
1053404212